
A daily dose of clinical news on Patient Care you may have missed.

Findings from a new study show the long-term benefits of COVID-19 vaccination to reduce inflammation after a breakthrough infection, say researchers.

Updates to CDC recommendations on influenza and COVID-19 vaccines and vaccine formulations will impact your choices during flu season this year.


The symptom of HMB may be present in up to 50% of reproductive-aged girls and women, most of whom may not even realize that what they are experiencing is abnormal.
Internist and obesity medicine specialist Alina Elperin, MD, details the most common cardiovascular complications that she has observed in patients with obesity.

CDC immunization recommendations for influenza, COVID-19, and RSV from the updated 2023 schedules are summarized in this Guideline Topline.

A daily dose of clinical news on Patient Care you may have missed.

The reduction in risk of CV events, the first to be shown by an antiobesity drug, was higher than expected and could help alter perceptions of the agents as "lifestyle drugs."

Blood pressure cuffs that are too large or too small for an individual's upper arm return measurements that may misguide therapeutic decisions, say study authors.

Which influenza vaccines does CDC recommend for older adults and how do the recommended shots differ from the others available? A short quiz.

You have tens of thousands of dollars worth of vaccines in your office fridge; your area loses power for 5 days after flooding rain. Now what?

A daily dose of clinical news on Patient Care you may have missed.
Obesity medicine specialist and internist Alina Elperin, MD, shares why screening for obstructive sleep apnea and metabolic disease in patients with obesity is crucial.

The oral gepant reduced monthly migraine days as well as mean monthly use of migraine rescue medication.

ACP CRC first screening age questioned; elders over age 75 years respond better to statins; 1 drink/day ups risk for HTN; OTC lifesaver #2; plus a triple virus assay.

The ACIP was unanimous in its recommendation for routine use of nirsevimab-alip to prevent RSV LRTD in newborns and young infants during their first RSV season.

The only head-to-head trial of mRNA COVID-19 vaccine safety in older adults finds one has a slight edge over the other, which might just be enough for some patients.

A daily dose of clinical news on Patient Care you may have missed.

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about?